FDA approved an update to the labeling for Zimmer Biomet's Mobi-C® Cervical Disc to include 7-year clinical results, showing the device to be statistically non-inferior in overall study success for 1-level use and statistically superior in overall study success for 2-level use.
The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in spinal fusion.
Total knee replacement patients and surgeons reported greater satisfaction with Ethicon's DERMABOND PRINEO Skin Closure System for surgical incisions vs. traditional skin staples.